Literature DB >> 22011243

Gas-foaming calcium phosphate cement scaffold encapsulating human umbilical cord stem cells.

Wenchuan Chen1, Hongzhi Zhou, Minghui Tang, Michael D Weir, Chongyun Bao, Hockin H K Xu.   

Abstract

Tissue engineering approaches are promising to meet the increasing need for bone regeneration. Calcium phosphate cement (CPC) can be injected and self-set to form a scaffold with excellent osteoconductivity. The objectives of this study were to develop a macroporous CPC-chitosan-fiber construct containing alginate-fibrin microbeads encapsulating human umbilical cord mesenchymal stem cells (hUCMSCs) and to investigate hUCMSC release from the degrading microbeads and proliferation inside the porous CPC construct. The hUCMSC-encapsulated microbeads were completely wrapped inside the CPC paste, with the gas-foaming porogen creating macropores in CPC to provide for access to culture media. Increasing the porogen content in CPC significantly increased the cell viability, from 49% of live cells in CPC with 0% porogen to 86% of live cells in CPC with 15% porogen. The alginate-fibrin microbeads started to degrade and release the cells inside CPC at 7 days. The released cells started to proliferate inside the macroporous CPC construct. The live cell number inside CPC increased from 270 cells/mm(2) at 1 day to 350 cells/mm(2) at 21 days. The pore volume fraction of CPC increased from 46.8% to 78.4% using the gas-foaming method, with macropore sizes of approximately 100 to 400 μm. The strength of the CPC-chitosan-fiber scaffold at 15% porogen was 3.8 MPa, which approximated the reported 3.5 MPa for cancellous bone. In conclusion, a novel gas-foaming macroporous CPC construct containing degradable alginate-fibrin microbeads was developed that encapsulated hUCMSCs. The cells had good viability while wrapped inside the porous CPC construct. The degradable microbeads in CPC quickly released the cells, which proliferated over time inside the porous CPC. Self-setting, strong CPC with alginate-fibrin microbeads for stem cell delivery is promising for bone tissue engineering applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22011243      PMCID: PMC3313611          DOI: 10.1089/ten.TEA.2011.0267

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  64 in total

1.  Strategic directions in tissue engineering.

Authors:  Peter C Johnson; Antonios G Mikos; John P Fisher; John A Jansen
Journal:  Tissue Eng       Date:  2007-12

2.  The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats.

Authors:  Esther W H Bodde; Otto C Boerman; Frans G M Russel; Antonios G Mikos; Paul H M Spauwen; John A Jansen
Journal:  J Biomed Mater Res A       Date:  2008-12-01       Impact factor: 4.396

3.  The influence of the acidic component of the gas-foaming porogen used in preparing an injectable porous calcium phosphate cement on its properties: acetic acid versus citric acid.

Authors:  Saeed Hesaraki; Ali Zamanian; Fatollah Moztarzadeh
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-07       Impact factor: 3.368

Review 4.  Fibrin: a versatile scaffold for tissue engineering applications.

Authors:  Tamer A E Ahmed; Emma V Dare; Max Hincke
Journal:  Tissue Eng Part B Rev       Date:  2008-06       Impact factor: 6.389

5.  Formation of interconnected macropores in apatitic calcium phosphate bone cement with the use of an effervescent additive.

Authors:  S Hesaraki; F Moztarzadeh; D Sharifi
Journal:  J Biomed Mater Res A       Date:  2007-10       Impact factor: 4.396

6.  An approach to modulate degradation and mesenchymal stem cell behavior in poly(ethylene glycol) networks.

Authors:  Gregory A Hudalla; Timothy S Eng; William L Murphy
Journal:  Biomacromolecules       Date:  2008-02-21       Impact factor: 6.988

7.  Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study.

Authors:  Philip Kasten; Ingo Beyen; Philipp Niemeyer; Reto Luginbühl; Marc Bohner; Wiltrud Richter
Journal:  Acta Biomater       Date:  2008-06-11       Impact factor: 8.947

8.  Mechanisms underlying the limited injectability of hydraulic calcium phosphate paste.

Authors:  Mohamed Habib; Gamal Baroud; Francois Gitzhofer; Marc Bohner
Journal:  Acta Biomater       Date:  2008-04-01       Impact factor: 8.947

9.  Fabrication and in vitro characterization of three-dimensional organic/inorganic scaffolds by robocasting.

Authors:  J Russias; E Saiz; S Deville; K Gryn; G Liu; R K Nalla; A P Tomsia
Journal:  J Biomed Mater Res A       Date:  2007-11       Impact factor: 4.396

10.  The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability.

Authors:  Chelsea N Salinas; Kristi S Anseth
Journal:  J Tissue Eng Regen Med       Date:  2008-07       Impact factor: 3.963

View more
  24 in total

1.  A transient cell-shielding method for viable MSC delivery within hydrophobic scaffolds polymerized in situ.

Authors:  Ruijing Guo; Catherine L Ward; Jeffrey M Davidson; Craig L Duvall; Joseph C Wenke; Scott A Guelcher
Journal:  Biomaterials       Date:  2015-03-27       Impact factor: 12.479

2.  Self-setting calcium orthophosphate formulations.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2013-11-12

Review 3.  Injectable foams for regenerative medicine.

Authors:  Edna M Prieto; Jonathan M Page; Andrew J Harmata; Scott A Guelcher
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-10-11

4.  The homing of bone marrow MSCs to non-osseous sites for ectopic bone formation induced by osteoinductive calcium phosphate.

Authors:  Guodong Song; Pamela Habibovic; Chongyun Bao; Jing Hu; Clemens A van Blitterswijk; Huipin Yuan; Wenchuan Chen; Hockin H K Xu
Journal:  Biomaterials       Date:  2013-01-05       Impact factor: 12.479

5.  Angiogenic and osteogenic regeneration in rats via calcium phosphate scaffold and endothelial cell co-culture with human bone marrow mesenchymal stem cells (MSCs), human umbilical cord MSCs, human induced pluripotent stem cell-derived MSCs and human embryonic stem cell-derived MSCs.

Authors:  Wenchuan Chen; Xian Liu; Qianmin Chen; Chongyun Bao; Liang Zhao; Zhimin Zhu; Hockin H K Xu
Journal:  J Tissue Eng Regen Med       Date:  2017-06-13       Impact factor: 3.963

6.  Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects.

Authors:  Wenchuan Chen; Jun Liu; Navid Manuchehrabadi; Michael D Weir; Zhimin Zhu; Hockin H K Xu
Journal:  Biomaterials       Date:  2013-09-18       Impact factor: 12.479

7.  Umbilical cord stem cells released from alginate-fibrin microbeads inside macroporous and biofunctionalized calcium phosphate cement for bone regeneration.

Authors:  Wenchuan Chen; Hongzhi Zhou; Michael D Weir; Chongyun Bao; Hockin H K Xu
Journal:  Acta Biomater       Date:  2012-03-03       Impact factor: 8.947

8.  Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering.

Authors:  Jun Liu; Hockin H K Xu; Hongzhi Zhou; Michael D Weir; Qianming Chen; Carroll Ann Trotman
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

9.  Prevascularization of a gas-foaming macroporous calcium phosphate cement scaffold via coculture of human umbilical vein endothelial cells and osteoblasts.

Authors:  WahWah Thein-Han; Hockin H K Xu
Journal:  Tissue Eng Part A       Date:  2013-04-16       Impact factor: 3.845

10.  A self-setting iPSMSC-alginate-calcium phosphate paste for bone tissue engineering.

Authors:  Ping Wang; Yang Song; Michael D Weir; Jinyu Sun; Liang Zhao; Carl G Simon; Hockin H K Xu
Journal:  Dent Mater       Date:  2015-12-29       Impact factor: 5.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.